Loading...
Loading...
Among the 4 tracked institutional investors we monitor, NMTC (NEUROONE MED TECHNOLOGIES CO) is held with a combined value of $1.83M across 2,394,682 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.20M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds reduced their position.
Total Institutional Value
$1.83M
Total Shares Held
2,394,682
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.20M | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $508.95K | 0.00% | -14.1% |
| 3 | CITADEL ADVISORS LLC | $78.81K | 0.00% | -31.6% |
| 4 | STATE STREET CORP | $46.20K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of NMTC with a position worth $1.20M, representing 0.00% of their portfolio. In total, 4 institutional investors hold NMTC with a combined value of $1.83M.
In the most recent quarter, 1 fund opened a new position in NMTC. Additionally, 2 reduced their positions.
Institutional investors hold $1.83M worth of NMTC stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $1.20M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For NMTC, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their NMTC positions.